← Back to signals
HSIC
BUYHenry Schein Inc.
Health Care
0.94
PEGY ratio
Rank #160
Why This Matters
This stock appears undervalued relative to its growth and dividend yield. Strong projected growth of 78.5% annually over 5 years.
HSIC trades at 23.4x earnings against 25.0% capped growth (actual 78.5%) (no dividend) (PEGY 0.94). Valuation looks favorable — the price is not fully reflecting the growth and yield on offer.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
- • Growth rate capped at 25% for PEGY calculation (actual: 78.5%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.
Scan date: 2026-06-05
Valuation
23.4x
P/E Ratio
Growth
78.5%
5yr EPS
Income
0.0%
Div Yield
PEGY Components
PEGY Score0.94
Denominator25.0%
EPS (TTM)$3.31
Market Data
Price$77.45
ExchangeNASDAQ
S&P 500Nasdaq 100
What Changed
PEGY Score
0.93→0.94(+0.01)
Rank
#155→#160(5 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only